[go: up one dir, main page]

TWI636790B - Use of mimosa pudica extracts for manufacture of composition for inhibiting mmp2 gene expression and collagen degradation - Google Patents

Use of mimosa pudica extracts for manufacture of composition for inhibiting mmp2 gene expression and collagen degradation Download PDF

Info

Publication number
TWI636790B
TWI636790B TW106124594A TW106124594A TWI636790B TW I636790 B TWI636790 B TW I636790B TW 106124594 A TW106124594 A TW 106124594A TW 106124594 A TW106124594 A TW 106124594A TW I636790 B TWI636790 B TW I636790B
Authority
TW
Taiwan
Prior art keywords
collagen
extract
grass
couple
skin
Prior art date
Application number
TW106124594A
Other languages
Chinese (zh)
Other versions
TW201907942A (en
Inventor
林詠翔
林于婷
Original Assignee
大江生醫股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大江生醫股份有限公司 filed Critical 大江生醫股份有限公司
Priority to TW106124594A priority Critical patent/TWI636790B/en
Priority to KR1020180008689A priority patent/KR102141095B1/en
Priority to CN201810727832.1A priority patent/CN109276588B/en
Application granted granted Critical
Publication of TWI636790B publication Critical patent/TWI636790B/en
Publication of TW201907942A publication Critical patent/TW201907942A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

本發明提供一種夫妻草萃取物用於製備抑制基質金屬蛋白酶2(MMP2)基因表現之組合物之用途,及一種夫妻草萃取物用於製備抑制膠原蛋白分解之組合物之用途。本發明之夫妻草萃取物係以水、醇類、或醇水混合物為溶劑對夫妻草進行萃取而製得。該夫妻草萃取物透過抑制皮膚纖維母細胞中MMP2的基因表現而降低皮膚中膠原蛋白的分解,因此有助於提升皮膚彈性與緊緻度、減少皮膚細紋與皺紋、及延緩皮膚老化。 The invention provides the use of a couple of grass extracts for preparing a composition for inhibiting the expression of matrix metalloproteinase 2 (MMP2) gene, and a use of a couples grass extract for preparing a composition for inhibiting the degradation of collagen. The extract of the couple's grass of the present invention is prepared by extracting the couple's grass with water, alcohol, or an alcohol-water mixture as a solvent. The marjoram extract reduces the decomposition of collagen in the skin by inhibiting the gene expression of MMP2 in the skin fibroblasts, thereby helping to improve skin elasticity and firmness, reduce skin fine lines and wrinkles, and delay skin aging.

Description

夫妻草萃取物用於製備抑制MMP2基因表現及膠原蛋白分解之組合物之用途 Use of marjoram grass extract for preparing composition for inhibiting MMP2 gene expression and collagen degradation

本發明係關於一種夫妻草萃取物的用途,特別係關於一種夫妻草萃取物用於製備抑制基質金屬蛋白酶2(MMP2)基因表現及抑制膠原蛋白分解之組合物之用途。 The present invention relates to the use of an extract of a couple of grasses, in particular to the use of an extract of a couple of grasses for preparing a composition that inhibits the expression of matrix metalloproteinase 2 (MMP2) gene and inhibits the degradation of collagen.

膠原蛋白(collagen)是動物體內含量高豐富的蛋白質,約占體內總蛋白質的25%。膠原蛋白主要分布於動物體內的結締組織之細胞外基質,例如韌帶、肌腱、軟骨、眼睛角膜,是結締組織中最主要的蛋白質,約占結締組織的20%~30%。膠原蛋白具有纖維狀的結構,能提供結締組織所需的力學支撐與強度,亦與血液凝結、傷口癒合、組織修復相關,使一種非常重要的結構性蛋白質。人體內的膠原蛋白由於多胜肽組成的差異可分為不同類型,其中,與皮膚構造最相關的是第一型、第三型、與第四型膠原蛋白。真皮層中含有第一型與第三型膠原蛋白,其與皮膚的水分保持及彈性增加有關,上皮組織下方的基底膜中含有第四型膠原蛋白,其與皮膚的水分輸送及養分維持有關。 Collagen (collagen) is a highly abundant protein in animals, accounting for about 25% of the total protein in the body. Collagen is mainly distributed in the extracellular matrix of connective tissue in animals, such as ligaments, tendons, cartilage, and cornea of the eye. It is the most important protein in connective tissue, accounting for about 20% to 30% of connective tissue. Collagen has a fibrous structure and can provide the mechanical support and strength required for connective tissue. It is also related to blood coagulation, wound healing, and tissue repair, making it a very important structural protein. Collagen in the human body can be divided into different types due to the difference in polypeptide composition. Among them, type I, type III, and type IV collagen are most relevant to the structure of the skin. The dermal layer contains type 1 and type 3 collagens, which are related to the skin's moisture retention and elasticity, and the basement membrane below the epithelial tissue contains type 4 collagens, which are related to the skin's water transport and nutrient maintenance.

隨著年齡增長及紫外線長期照射,皮膚中的膠原蛋白會流失並導致皮膚含水量減少,而皮膚的乾燥狀態會進一步造成皮膚彈性變差、皺紋生成、及毛孔粗大。因此,設法補充皮膚膠原蛋白、提升膠原蛋白的合成、及減少膠原蛋白的分解已成為減緩皮膚老化、維持皮膚健康的研究重心。由於皮膚表皮層的阻隔作用,直接將含有膠原蛋白的保養品塗抹於皮膚表面無法有效補充皮膚深層的膠原蛋白。另一方面,若以口服方式攝取膠原蛋白,由於大分子的膠 原蛋白在消化道被分解為小分子的胺基酸,人體各部位獲得該些胺基酸後未必會合成所需的膠原蛋白,故口服膠原蛋白以提升皮膚膠原蛋白合成的效果有限。 With age and long-term UV exposure, collagen in the skin will be lost and the skin's water content will decrease. The dry state of the skin will further cause poor skin elasticity, wrinkle formation, and enlarged pores. Therefore, efforts to replenish skin collagen, improve collagen synthesis, and reduce collagen degradation have become the focus of research on slowing skin aging and maintaining skin health. Due to the barrier effect of the epidermal layer of the skin, applying skin care products containing collagen directly to the skin surface cannot effectively supplement the deep collagen of the skin. On the other hand, if collagen is taken orally, The original protein is broken down into small molecules of amino acids in the digestive tract. After obtaining these amino acids in various parts of the human body, it may not necessarily synthesize the collagen required. Therefore, the effect of oral collagen to enhance the synthesis of skin collagen is limited.

有鑒於此,開發一種能有效抑制膠原蛋白分解的新穎組成物以達到減少膠原蛋白流失、避免皮膚老化的目標,實有其必要。 In view of this, it is necessary to develop a novel composition that can effectively inhibit the breakdown of collagen to reduce the loss of collagen and avoid skin aging.

緣此,本發明之一目的在提供一種夫妻草(Mimosa pudica)萃取物用於製備抑制基質金屬蛋白酶2(matrix metalloproteinase 2,MMP2)基因表現之組合物之用途。 Therefore, an object of the present invention is to provide a use of Mimosa pudica extract for preparing a composition for inhibiting the expression of matrix metalloproteinase 2 (MMP2) gene.

本發明之另一目的在提供一種前述夫妻草萃取物用於製備抑制膠原蛋白分解之組合物之用途,其中該夫妻草萃取物係以一溶劑萃取一夫妻草而獲得。 Another object of the present invention is to provide a use of the aforesaid extract of a couple of grasses for preparing a composition for inhibiting the degradation of collagen, wherein the extract of a couple of grasses is obtained by extracting a couple of grasses with a solvent.

在本發明之一實施例中,該溶劑為水、醇類、或醇水混合物,該溶劑與夫妻草之液固比為5~20:1~5,且該萃取係在50℃~100℃進行。 In one embodiment of the present invention, the solvent is water, alcohols, or a mixture of alcohol and water, and the liquid-to-solid ratio of the solvent to the couple's grass is 5-20: 1-5, and the extraction system is at 50 ° C to 100 ° C. get on.

在本發明之一實施例中,該夫妻草萃取物係為一夫妻草之水萃取物,其濃度為至少0.5mg/mL。 In one embodiment of the present invention, the extract of the couple's grass is a water extract of the couple's grass, and its concentration is at least 0.5 mg / mL.

在本發明之一實施例中,該膠原蛋白為第四型膠原蛋白。 In one embodiment of the present invention, the collagen is type IV collagen.

本發明以水、醇類、或醇水混合物為溶劑所萃取得之夫妻草萃取物能透過抑制皮膚纖維母細胞中MMP2的基因表現而減少細胞外基質中第四型膠原蛋白的降解,最終達到增加皮膚中膠原蛋白含量的效果,因此有助於提升皮膚彈性與緊緻度、減少皮膚細紋與皺紋、及延緩皮膚老化。故本發明夫妻草萃取物可用於製備抑制MMP2基因表現及抑制膠原蛋白分解之組合物,該組合物可為粉末狀、顆粒狀、液狀、膠狀或膏狀,且可製成食品、飲品、藥品、試劑或營養補充劑,藉由口服、皮膚塗抹等方式給予一個體。 In the present invention, the extract of Marjoram humilis extracted with water, alcohols, or a mixture of alcohol and water as a solvent can reduce the degradation of type IV collagen in the extracellular matrix by inhibiting the gene expression of MMP2 in skin fibroblasts, and finally achieve The effect of increasing the collagen content in the skin, thus helping to improve skin elasticity and firmness, reduce skin fine lines and wrinkles, and delay skin aging. Therefore, the extract of the couple's grass of the present invention can be used to prepare a composition for inhibiting the expression of the MMP2 gene and inhibiting the decomposition of collagen. The composition can be powder, granule, liquid, gel or paste, and can be made into food and drink , Medicines, reagents or nutritional supplements, given to a body by oral administration, skin application, etc.

以下將配合圖式進一步說明本發明的實施方式,下述所列舉的實施例係用以闡明本發明之發明特點及應用,而非以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 The embodiments of the present invention will be further described below with reference to the drawings. The examples listed below are intended to clarify the features and applications of the invention, but not to limit the scope of the invention. Anyone skilled in the art will not depart from it. Within the spirit and scope of the present invention, some modifications and retouching can be done. Therefore, the protection scope of the present invention shall be determined by the scope of the attached patent application.

圖1顯示經本發明夫妻草萃取物處理的人類皮膚纖維母細胞及控制組人類皮膚纖維母細胞的膠原蛋白相對產量。 FIG. 1 shows the relative collagen production of human skin fibroblasts and human skin fibroblasts in the control group treated with the extract of the couple's grass.

圖2顯示經過本發明夫妻草萃取物處理之人類皮膚纖維母細胞中MMP2基因的相對表現量。 FIG. 2 shows the relative expression of the MMP2 gene in human skin fibroblasts treated with the extract of Acanthopanax splendens.

本發明提供一種夫妻草萃取物用於製備抑制膠原蛋白分解之組合物之用途。本發明之夫妻草萃取物係以一溶劑萃取一夫妻草的植株而獲得,其中,該溶劑為水、醇類、或醇水混合物,該溶劑與該夫妻草之液固比為5~20:1~5,且該萃取係在50℃~100℃進行。透過膠原蛋白含量試驗及膠原蛋白分解相關基因之表現量分析,本發明夫妻草萃取物被證實能提高人類皮膚纖維母細胞的膠原蛋白產量,且該產量之增加與MMP2基因之表現量減少有關。因此,本發明之夫妻草萃取物亦可用於製備抑制MMP2基因表現之組合物。 The invention provides the use of a couple's grass extract for preparing a composition for inhibiting the degradation of collagen. The extract of the couple's grass of the present invention is obtained by extracting a plant of the couple's grass with a solvent, wherein the solvent is water, alcohol, or a mixture of alcohol and water, and the liquid-solid ratio of the solvent to the couple's grass is 5-20: 1 to 5, and the extraction is performed at 50 ° C to 100 ° C. Through the collagen content test and the expression analysis of genes related to collagen degradation, the extract of the couple's grass of the present invention was confirmed to increase the collagen production of human skin fibroblasts, and the increase in the production was related to the decrease in the expression of the MMP2 gene. Therefore, the extract of Leymus chinensis according to the present invention can also be used to prepare a composition for inhibiting the expression of the MMP2 gene.

定義definition

本文中所使用數值為近似值,所有實驗數據皆表示在20%的範圍內,較佳為在10%的範圍內,最佳為在5%的範圍內。 The values used in this article are approximate. All experimental data are shown in the range of 20%, preferably in the range of 10%, and most preferably in the range of 5%.

材料與方法Materials and Methods 材料material

自Gibco購買含Earle’s平衡鹽溶液之Eagle’s最低基本培養基(Eagle’s minimum essential medium,簡稱MEM培養基),胎牛血清(fetal bovine serum,簡稱FBS),非必需胺基酸,碳酸氫鈉,丙酮酸鈉,及磷酸緩衝鹽溶液(phosphate buffered saline,簡稱PBS溶液)。 Eagle's Minimum Essential Medium (MEM medium), Fetal bovine serum (FBS), non-essential amino acids, sodium bicarbonate, sodium pyruvate, purchased from Gibco with Earle's balanced salt solution, And phosphate buffered saline (PBS buffer solution).

細胞培養Cell culture

以下實施例使用人類皮膚纖維母細胞(Human skin fibroblast)CCD-966SK(BCRC 60153)進行實驗。人類皮膚纖維母細胞在37℃、5%二氧化碳的條件下培養於添加10%FBS、0.1mM非必需胺基酸、1.5g/L碳酸氫鈉、1mM丙酮酸鈉之MEM培養基,以下稱細胞培養基。 The following examples use human skin fibroblast CCD-966SK (BCRC 60153) for experiments. Human skin fibroblasts were cultured at 37 ° C and 5% carbon dioxide in a MEM medium supplemented with 10% FBS, 0.1 mM non-essential amino acid, 1.5 g / L sodium bicarbonate, and 1 mM sodium pyruvate, hereinafter referred to as cell culture medium. .

膠原蛋白含量試驗Collagen content test

本發明利用可溶性膠原蛋白分析套組(Sircol Soluble Collagen Assay Kit,Bicolor)測定細胞所分泌膠原蛋白的含量,其步驟簡述如下。取1000μL 細胞培養基與200μL膠原蛋白分離/濃縮試劑混合,於4℃下翻轉培養一段時間後,以12000rpm之轉速離心該混合液10分鐘,移除上清液。其次,將餘下沉澱與1000μL Sircol染劑混合30分鐘,再以12000rpm之轉速離心該染劑混合液10分鐘以形成膠原蛋白沉澱物。待移除上清液,先以750μL酸性鹽溶液清洗該膠原蛋白沉澱物並移除多餘液體,添加250μL鹼性試劑以溶解該膠原蛋白沉澱物,再使用酵素免疫分析儀(ELISA reader,BioTek)測量該膠原蛋白溶液在波長555nm的吸光值。對照水溶性膠原蛋白標準品的標準曲線,可計算得待測之細胞培養基中的膠原蛋白含量。統計分析係使用Excel軟體之學生t檢定進行判定。 In the present invention, a soluble collagen analysis kit (Sircol Soluble Collagen Assay Kit, Bicolor) is used to determine the content of collagen secreted by cells. The steps are briefly described below. Take 1000 μL The cell culture medium was mixed with 200 μL of a collagen separation / concentration reagent, and after being inverted at 4 ° C. for a period of time, the mixture was centrifuged at 12000 rpm for 10 minutes, and the supernatant was removed. Next, the remaining precipitate was mixed with 1000 μL of Sircol dye for 30 minutes, and the dye mixture was centrifuged at 12000 rpm for 10 minutes to form a collagen precipitate. To remove the supernatant, first wash the collagen precipitate with 750 μL of acidic salt solution and remove excess liquid, add 250 μL of alkaline reagent to dissolve the collagen precipitate, and then use an enzyme immunoassay analyzer (ELISA reader, BioTek) The absorbance of the collagen solution at a wavelength of 555 nm was measured. By comparing the standard curve of the water-soluble collagen standard, the collagen content in the cell culture medium to be measured can be calculated. Statistical analysis is performed using Student's t-test of Excel software.

基因表現量分析Gene expression analysis

本發明以定量聚合酶鏈鎖反應(quantitative polymerase chain reaction,簡稱Q-PCR)測定細胞中與膠原蛋白分解有關之酵素之基因表現量,其步驟簡述如下。依據廠商使用說明,利用核糖核酸萃取套組(RNA Extraction Kit,Geneaid)自細胞分離出RNA後,於37℃下以反轉錄酶SuperScript® III Reverse Transcriptase(Invitrogen)將RNA反轉錄為互補去氧核醣核酸(cDNA),其次,利用Q-PCR套組(KAPA CYBR FAST qPCR Kit(2X),KAPA Biosystems)、針對MMP2基因之正向引子5’-GATACCCCTTTGACGGTAAGGA-3’(SEQ ID NO:1)與反向引子5’-CCTTCTCCCAAGGTCCATAGC-3’(SEQ ID NO:2)、及聚合酶鏈鎖反應儀(StepOnePlusTM Real-Time PCR Systems)對該cDNA進行PCR,以取得基因表現量數據。 In the present invention, the quantitative polymerase chain reaction (Q-PCR) is used to determine the gene expression of enzymes related to the degradation of collagen in cells. The steps are briefly described below. According to the manufacturer's instructions, RNA was isolated from the cells using the RNA Extraction Kit (Geneaid), and the RNA was reverse transcribed into complementary deoxyribose at 37 ° C using the reverse transcriptase SuperScript® III Reverse Transcriptase (Invitrogen). Nucleic acid (cDNA), followed by Q-PCR kit (KAPA CYBR FAST qPCR Kit (2X), KAPA Biosystems), forward primer 5'-GATACCCCTTTGACGGTAAGGA-3 '(SEQ ID NO: 1) against MMP2 gene and anti- This primer was 5′-CCTTCTCCCAAGGTCCATAGC-3 ′ (SEQ ID NO: 2) and a polymerase chain reaction system (StepOnePlus Real-Time PCR Systems) was used to perform PCR on the cDNA to obtain gene expression data.

實施例1Example 1 夫妻草萃取物之製備Preparation of Marjoram grass extract

首先,將夫妻草洗淨晾乾,以均質機將夫妻草磨碎。其次,以水、醇類、或醇水混合物為溶劑對夫妻草均質物進行萃取,該溶劑與夫妻草均質物混合之液固比為5~20:1~5。萃取溫度為介於50℃~100℃,較佳為75℃~95℃。本實施例中萃取時間為0.5~2小時。 First, the couple grass was washed and dried, and the couple grass was ground with a homogenizer. Secondly, water, alcohols, or a mixture of alcohol and water are used as a solvent to extract the homogenate of the husband and wife, and the liquid-solid ratio of the solvent and the homogenate of the husband and wife is 5 ~ 20: 1 ~ 5. The extraction temperature is between 50 ° C and 100 ° C, preferably between 75 ° C and 95 ° C. In this embodiment, the extraction time is 0.5 to 2 hours.

經上述萃取步驟所得夫妻草萃取物冷卻至室溫後,可以400目(mesh)之濾網過濾,以移除殘餘固體物。該過濾後的夫妻草萃取物可進一步在45℃~70℃進行減壓濃縮而獲得一濃縮產物。為獲得固態的夫妻草萃取物,可 將前述經減壓濃縮的夫妻草萃取物以噴霧乾燥方式去除溶劑,因此獲得夫妻草萃取物粉末。 After cooling down to room temperature, the extract of the couple's grass obtained through the above-mentioned extraction step can be filtered through a 400 mesh filter to remove residual solids. The filtered Marjoram grass extract can be further concentrated under reduced pressure at 45 ° C to 70 ° C to obtain a concentrated product. In order to obtain The solvent extract was removed by spray-drying the above-mentioned condensed fragrant grass extract under reduced pressure, thereby obtaining a fragrant grass extract powder.

實施例2Example 2 夫妻草萃取物提升纖維母細胞之膠原蛋白產量Marjoram extract improves fibroblast collagen production

為檢驗本發明夫妻草萃取物對皮膚細胞之膠原蛋白產量的影響,本實施例以膠原蛋白含量試驗分析人類皮膚纖維母細胞CCD-966SK經夫妻草之水萃取物處理後,其膠原蛋白產出量的變化。首先,將人類皮膚纖維母細胞依2×104細胞/孔接種於含有500μL細胞培養基的24孔盤的各孔,在37℃下培養24小時後,移除細胞培養基並以PBS溶液清洗細胞。其次,將500μL、1mg/mL夫妻草之水萃取物與500μL不含FBS之細胞培養基添加至各孔細胞,或僅以500μL不含FBS之細胞培養基處理細胞以作為控制組。前述二組細胞在37℃下培養48小時後,自各孔收集細胞培養基,測定其中膠原蛋白含量。 In order to test the effect of the extract of the plant of the present invention on the collagen production of skin cells, this example uses a collagen content test to analyze the human skin fibroblast CCD-966SK treated with the water extract of the plant of the plant and its collagen production. Volume change. First, human skin fibroblasts were seeded at 2 × 10 4 cells / well into each well of a 24-well plate containing 500 μL of cell culture medium, and after being cultured at 37 ° C. for 24 hours, the cell culture medium was removed and the cells were washed with a PBS solution. Secondly, 500 μL, 1 mg / mL water extract of Amaryllis and 500 μL of FBS-free cell culture medium were added to each well cell, or the cells were treated with only 500 μL of FBS-free cell culture medium as a control group. After the two groups of cells were cultured at 37 ° C for 48 hours, the cell culture medium was collected from each well, and the collagen content was measured.

圖1顯示經本發明夫妻草萃取物處理的人類皮膚纖維母細胞及控制組細胞的膠原蛋白相對產量。依據圖1,相較於控制組人類皮膚纖維母細胞,對人類皮膚纖維母細胞施予夫妻草萃取物明顯提升細胞培養基中的膠原蛋白含量約8.3倍。此結果顯示本發明夫妻草萃取物具有增加皮膚纖維母細胞之膠原蛋白產量的功效。 FIG. 1 shows the relative collagen production of human skin fibroblasts and cells in the control group treated with the extract of the couple's grass. According to FIG. 1, compared with the control group of human skin fibroblasts, the application of the extract of the grass to the human skin fibroblasts significantly increased the collagen content in the cell culture medium by about 8.3 times. This result shows that the extract of the marjoram grass of the present invention has the effect of increasing the collagen production of skin fibroblasts.

實施例3Example 3 夫妻草萃取物抑制膠原蛋白分解相關基因之表現Expression of Marjoram grass extract inhibiting genes related to collagen degradation

為進一步探討本發明夫妻草萃取物對膠原蛋白分解酵素的基因表現調節作用,本實施例以Q-PCR測定人類皮膚纖維母細胞CCD-966SK(BCRC 60153)經夫妻草之水萃取物處理後,其膠原蛋白分解相關基因之表現量變化。首先,將人類皮膚纖維母細胞依1.5×105個細胞/孔接種於含有2mL細胞培養基的6孔盤的各孔,置於37℃下培養。其次,以0.5mg/mL或1mg/mL夫妻草之水萃取物處理細胞24小時,再收集經處理細胞以進行Q-PCR。控制組的人類皮膚纖維母細胞係經不含夫妻草水萃取物之細胞培養基處理。 In order to further explore the regulatory effect of the extract of the plant of the present invention on the collagen-degrading enzyme, Q-PCR was used to determine the human skin fibroblasts CCD-966SK (BCRC 60153) treated with the water extract of the plant. Changes in the expression of collagen-decomposition-related genes. First, human skin fibroblasts were seeded at 1.5 × 10 5 cells / well into each well of a 6-well plate containing 2 mL of cell culture medium, and cultured at 37 ° C. Next, the cells were treated with 0.5 mg / mL or 1 mg / mL water extract of Amaryllis for 24 hours, and the treated cells were collected for Q-PCR. The human skin fibroblast cell line of the control group was treated with a cell culture medium that did not contain a water extract of the marjoram grass.

上述人類皮膚纖維母細胞中基質金屬蛋白酶2(MMP2)基因的相對表現量如圖2所示,圖中縱座標之基因相對表現量表示相對於控制組細胞中MMP2基因之RNA表現量的倍數。MMP2又稱第四型膠原蛋白水解酶(type IV collagenase),由細胞合成後被分泌至細胞外基質,其功能包括分解上皮組織下方基底膜中的第四型膠原蛋白。依據圖2,對人類皮膚纖維母細胞施予濃度0.5mg/mL以上的夫妻草萃取物明顯降低MMP2的基因表現。當前述細胞以0.5mg/mL夫妻草萃取物處理,其MMP2基因表現量約為控制組細胞的46%。此結果說明本發明夫妻草萃取物能抑制皮膚纖維母細胞中MMP2的基因表現,因此對皮膚中膠原蛋白的降解有抑制效果。 The relative expression amount of the matrix metalloproteinase 2 (MMP2) gene in the human skin fibroblasts is shown in FIG. 2. The relative expression amount of the gene in the vertical axis represents a multiple of the expression amount of the RNA relative to the MMP2 gene in the control group cells. MMP2 is also known as type IV collagenase collagenase), which is synthesized by cells and secreted into the extracellular matrix, and its functions include breaking down type IV collagen in the basement membrane below the epithelial tissue. According to FIG. 2, the administration of the extract of Aquilegia japonica on human skin fibroblasts at a concentration of 0.5 mg / mL or more significantly reduced the gene expression of MMP2. When the aforesaid cells were treated with 0.5 mg / mL extracts of Aquilegia japonica, the expression of MMP2 gene was about 46% of the cells in the control group. This result indicates that the extract of the couple's grass can inhibit the gene expression of MMP2 in skin fibroblasts, and therefore has an inhibitory effect on the degradation of collagen in the skin.

綜上所述,本發明以水、醇類、或醇水混合物為溶劑所萃取得之夫妻草萃取物能經由抑制皮膚纖維母細胞中MMP2的基因表現,減少細胞外基質中第四型膠原蛋白的降解,最終達到增加皮膚中膠原蛋白含量的效果。因此,本發明夫妻草萃取物可用於製備抑制MMP2基因表現及抑制膠原蛋白分解之組合物,該組合物可為粉末狀、顆粒狀、液狀、膠狀或膏狀,且可製成食品、飲品、藥品、試劑或營養補充劑,藉由口服、皮膚塗抹等方式給予一個體。 To sum up, the water extract, the water extract, the alcohol extract, or the alcohol-water mixture extracted by the present invention can reduce the MMP2 gene expression in the skin fibroblast cells and reduce the type IV collagen in the extracellular matrix. Degradation, and ultimately achieve the effect of increasing collagen content in the skin. Therefore, the extract of the marjoram grass of the present invention can be used to prepare a composition for inhibiting the expression of MMP2 gene and inhibiting the degradation of collagen. The composition can be powder, granular, liquid, gel or paste, and can be made into food, Drinks, medicines, reagents or nutritional supplements are administered to a body by oral administration, skin application, and the like.

<110> 大江生醫股份有限公司 <110> Dajiang Biomedical Co., Ltd.

<120> 夫妻草萃取物用於製備抑制MMP2基因表現及膠原蛋白分解之組合物之用途 <120> Use of marjoram grass extract for preparing composition for inhibiting MMP2 gene expression and collagen degradation

<130> 106B0169-I1 <130> 106B0169-I1

<160> 2 <160> 2

<170> PatentIn version 3.5 <170> PatentIn version 3.5

<210> 1 <210> 1

<211> 22 <211> 22

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 1 <400> 1

<210> 2 <210> 2

<211> 21 <211> 21

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> PCR引子 <223> PCR primer

<400> 2 <400> 2

Claims (3)

一種夫妻草萃取物用於製備抑制基質金屬蛋白酶2(MMP2)基因表現之組合物之用途,其中該夫妻草萃取物係以一選自於水、醇類、及醇水混合物之溶劑在50℃至100℃萃取一夫妻草而獲得,且該溶劑與該夫妻草之液固比為5~20:1~5。A mangosteen extract is used for preparing a composition for inhibiting the expression of matrix metalloproteinase 2 (MMP2) gene, wherein the mangosteen extract is a solvent selected from water, alcohols, and a mixture of alcohol and water at 50 ° C. It is obtained by extracting a couple grass at 100 ° C, and the liquid-solid ratio of the solvent to the couple grass is 5 ~ 20: 1 ~ 5. 如申請專利範圍第1項所述之用途,其中該夫妻草萃取物係為一夫妻草之水萃取物,其濃度為至少0.5mg/mL。The use according to item 1 of the scope of the patent application, wherein the extract of the couple's grass is a water extract of the couple's grass and its concentration is at least 0.5 mg / mL. 如申請專利範圍第1項所述之用途,其中該組合物係以口服或皮膚塗抹的方式給予。The use according to item 1 of the scope of patent application, wherein the composition is administered orally or by skin application.
TW106124594A 2017-07-21 2017-07-21 Use of mimosa pudica extracts for manufacture of composition for inhibiting mmp2 gene expression and collagen degradation TWI636790B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TW106124594A TWI636790B (en) 2017-07-21 2017-07-21 Use of mimosa pudica extracts for manufacture of composition for inhibiting mmp2 gene expression and collagen degradation
KR1020180008689A KR102141095B1 (en) 2017-07-21 2018-01-24 Use of Mimosa pudica extracts for manufacture of composition for inhibiting MMP2 gene expression and collagen degradation
CN201810727832.1A CN109276588B (en) 2017-07-21 2018-07-04 Application of wife extract in preparing composition for inhibiting MMP2 gene expression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106124594A TWI636790B (en) 2017-07-21 2017-07-21 Use of mimosa pudica extracts for manufacture of composition for inhibiting mmp2 gene expression and collagen degradation

Publications (2)

Publication Number Publication Date
TWI636790B true TWI636790B (en) 2018-10-01
TW201907942A TW201907942A (en) 2019-03-01

Family

ID=64797430

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106124594A TWI636790B (en) 2017-07-21 2017-07-21 Use of mimosa pudica extracts for manufacture of composition for inhibiting mmp2 gene expression and collagen degradation

Country Status (3)

Country Link
KR (1) KR102141095B1 (en)
CN (1) CN109276588B (en)
TW (1) TWI636790B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111329943A (en) * 2018-12-19 2020-06-26 山东理工大学 A compound herbal preparation with antihyperglycemic and antioxidant effects for treating diabetes

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110123865A (en) * 2019-05-07 2019-08-16 嘉兴市爵拓科技有限公司 Composition comprising man and wife's grass extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290993B1 (en) * 1999-07-23 2001-09-18 E-L Management Corp. Compositions containing mimosa phenolic compounds
CN102274288B (en) * 2010-06-09 2013-07-17 台湾糖业股份有限公司 Use of angelica extract as a medicament for preventing skin aging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835427B1 (en) * 2002-02-04 2006-08-04 Nuxe Lab COSMETOLOGICAL AND / OR DERMATOLOGICAL COMPOSITION BASED ON BARBATIMAO EXTRACT
WO2006053415A1 (en) 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290993B1 (en) * 1999-07-23 2001-09-18 E-L Management Corp. Compositions containing mimosa phenolic compounds
CN102274288B (en) * 2010-06-09 2013-07-17 台湾糖业股份有限公司 Use of angelica extract as a medicament for preventing skin aging

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111329943A (en) * 2018-12-19 2020-06-26 山东理工大学 A compound herbal preparation with antihyperglycemic and antioxidant effects for treating diabetes

Also Published As

Publication number Publication date
CN109276588A (en) 2019-01-29
KR20190050927A (en) 2019-05-14
KR102141095B1 (en) 2020-08-05
TW201907942A (en) 2019-03-01
CN109276588B (en) 2022-08-12

Similar Documents

Publication Publication Date Title
TWI659746B (en) Composition containing collagen peptide, elastin peptide, and proteoglycan
US10251824B2 (en) Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method
CN108699519A (en) The stem cell-derived allochthon containing the raised growth factor
US8778422B2 (en) Compositions for treating degenerative joint diseases
CN106519020A (en) Functional peptide with cosmetic efficacy and preparation method and application thereof
TWI734474B (en) Use of annona muricata ferments in the manufacture of a composition for skin tightening, anti-glycation, and gene regulation
TW201536341A (en) Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging
TW201517930A (en) Use of starfish extract for manufacture of composition for enhancing secretion of collagen
TWI636790B (en) Use of mimosa pudica extracts for manufacture of composition for inhibiting mmp2 gene expression and collagen degradation
US20220047495A1 (en) Rosewood extract
CN102821751A (en) Human dermal epithelial cell growth promoter, and skin composition for external use and cosmetic material including the same
CN104087640A (en) Cornua cervi pantotrichum polypeptide serial extraction method beneficial to skin or mucosa absorption
CN110710682A (en) Use of buckwheat seed coat extract to enhance mitochondrial activity, promote expression of anti-aging genes, and inhibit protein glycation
CN106890314B (en) Application of pearl extract in preparing medicine, health product and cosmetics for inhibiting generation of presenilin
TWI784298B (en) Use of bioactive compound for preparing a composition promoting skin collagen production and enhancing skin collagen density
CN114939132B (en) Use of red dragon fruit ovule extract for preparing a composition that inhibits glycation of collagen
TWI736759B (en) Use of peach resin extracts for promoting gene expression of timp1, col1a2, mmp, tgm1, krt1, aqp3, gba and has3
TWI734032B (en) Use of tartary buckwheat husk extracts for improving mitochondrial activity
TWI801770B (en) Uses of nostoc sphaeroides extract for reducing body fat and enhancing skin appearance
CN109182434A (en) A kind of preparation method of the quinoa polypeptide hydrolysate with anti-obesity activity
TWI690323B (en) Use of ascophyllum nodosum extracts for regulating expression of gene groups
TWI688410B (en) Use of dragon fruit ovule extracts for retarding skin aging
CN109846943A (en) Use of peach gum extract to promote collagen proliferation or inhibit collagen degradation and increase skin water retention capacity
CN117143189A (en) A polypeptide that promotes bone growth, a bone growth-promoting composition and preparation methods and applications
TW202402265A (en) Black apple extracts for preparing a composition for improving skin condition